approved EB-1B
Scientist
Pharmaceutical Sciences · India · 2023-03-15
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 2 criteria metScholarly Books or Articles (Met)
The petitioner authored 13 peer-reviewed scientific articles in high-impact journals.
Judging the Work of Others (Met)
The petitioner completed at least 23 reviews for professional journals in her field.
Original Scientific or Scholarly Research Contributions (Met)
Her work on Cjoc42 and cancer drug efficacy was recognized as original and influential by independent experts.
Why This Petition Was Approved
The petition was approved based on meeting EB-1B criteria including a record of 13 peer-reviewed scientific articles in high-impact journals and 224 citations. Additionally, the petitioner demonstrated her expertise through 23 completed peer reviews for professional journals and provided expert testimony regarding her original contributions to cancer drug delivery.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
- 13 peer-reviewed scientific articles in prestigious journals
- 224 citations according to Google Scholar
- 23 journal reviews conducted to date
- Ph.D. in Pharmaceutical Sciences in Medicinal Chemistry
- Four expert recommendation letters
Similar Cases
Research Assistant
Pharmaceuticals · China
WeGreened EB-1B approved
Minnesota 761 days 2025-04-01
The petition was approved based on the petitioner's 15 peer-reviewed articles and 215 citations, with several papers ranking in the top 10% of the field. Additionally, her participation in 10 peer reviews for prestigious journals and the global application of her research by independent scholars satisfied the EB-1B requirements.
Research Scientist
Research and Development · India
WeGreened EB-1B approved
Pennsylvania 9 days 2022-12-07
The petition was approved based on the petitioner's Ph.D. and 9 years of contributions, including 9 peer-reviewed scientific articles in high-impact journals. His work garnered 37 citations and he completed over 127 peer reviews for journals and conferences. These metrics satisfied the EB-1B criteria for scholarly publications, original contributions, and judging the work of others.
Assistant Professor
Research and Development · India
WeGreened EB-1B approved
7 days 2023-09-25
The petition was approved based on meeting the EB-1B criteria for international recognition as an outstanding researcher. Key metrics included 14 peer-reviewed scientific articles, one book chapter, and 201 citations demonstrating significant influence. Additionally, the petitioner's record of 100 peer reviews for acclaimed journals established his prestige and standing in the field.
Postdoctoral Researcher
Biotechnology · China
WeGreened EB-1B rfe approved
Massachusetts 557 days 2025-10-20
The petition was approved based on the petitioner's 14 peer-reviewed journal articles and 655 citations, which established his international influence in cell biology. His completion of 25 peer reviews for leading journals satisfied the judging criteria for EB-1B. The evidence successfully demonstrated his original scientific research contributions to the field of cancer treatment and molecular biochemistry.
Frequently Asked Questions
A approved EB-1B (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-03-15.
Browse all casesAt a Glance
Outcome approved
Processing 49 days
Criteria Met 3 / 2
Evidence Types 5
EB-1B Case Data
Scraped Case Data
Total Cases 68
Success Rate 98.5%
Sustained 67
Dismissed 1
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist